167 related articles for article (PubMed ID: 34837511)
1. Additional MRI for initial M-staging in pancreatic cancer: a cost-effectiveness analysis.
Gassert FG; Ziegelmayer S; Luitjens J; Gassert FT; Tollens F; Rink J; Makowski MR; Rübenthaler J; Froelich MF
Eur Radiol; 2022 Apr; 32(4):2448-2456. PubMed ID: 34837511
[TBL] [Abstract][Full Text] [Related]
2. Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis.
Burian E; Palla B; Callahan N; Pyka T; Wolff C; von Schacky CE; Schmid A; Froelich MF; Rübenthaler J; Makowski MR; Gassert FG
Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3870-3877. PubMed ID: 35606526
[TBL] [Abstract][Full Text] [Related]
3.
Gassert FG; Rübenthaler J; Cyran CC; Rink JS; Schwarze V; Luitjens J; Gassert FT; Makowski MR; Schoenberg SO; Mayerhoefer ME; Tamandl D; Froelich MF
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3268-3276. PubMed ID: 33686457
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of short-protocol emergency brain MRI after negative non-contrast CT for minor stroke detection.
Puhr-Westerheide D; Froelich MF; Solyanik O; Gresser E; Reidler P; Fabritius MP; Klein M; Dimitriadis K; Ricke J; Cyran CC; Kunz WG; Kazmierczak PM
Eur Radiol; 2022 Feb; 32(2):1117-1126. PubMed ID: 34455484
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of 18F-FDG PET/CT, MRI and CE-CT in selection of colorectal liver metastases eligible for ablation - A cost-effectiveness analysis.
Schnitzer ML; Buchner J; Biechele G; Grawe F; Ingenerf M; von Münchhausen N; Kaiser CG; Kunz WG; Froelich MF; Schmid-Tannwald C; Rübenthaler J
Eur J Radiol; 2023 Jun; 163():110803. PubMed ID: 37004464
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of MRI, CE-CT and 18F-FDG PET/CT for detecting colorectal liver metastases eligible for hepatic resection.
Schnitzer ML; von Münchhausen N; Biechele G; Runtemund J; Grawe F; Geyer T; Kaiser CG; Haag F; Rübenthaler J; Froelich MF
Front Oncol; 2023; 13():1161738. PubMed ID: 37554160
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
[TBL] [Abstract][Full Text] [Related]
8. Performing Gadoxetic Acid-Enhanced MRI After CT for Guiding Curative Treatment of Early-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.
Suh CH; Kim KW; Park SH; Kim SY; Woo DC; Shin S; Pyo J; Shinagare AB; Ramaiya NH; Lim YS
AJR Am J Roentgenol; 2018 Feb; 210(2):W63-W69. PubMed ID: 29091004
[TBL] [Abstract][Full Text] [Related]
9. Cost-effective imaging for resectability of liver lesions in colorectal cancer: an economic decision model.
Saing S; Haywood P; Duncan JK; Ma N; Cameron AL; Goodall S
ANZ J Surg; 2018 Jun; 88(6):E507-E511. PubMed ID: 28982209
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of EOB-MRI for Hepatocellular Carcinoma in Japan.
Nishie A; Goshima S; Haradome H; Hatano E; Imai Y; Kudo M; Matsuda M; Motosugi U; Saitoh S; Yoshimitsu K; Crawford B; Kruger E; Ball G; Honda H
Clin Ther; 2017 Apr; 39(4):738-750.e4. PubMed ID: 28363694
[TBL] [Abstract][Full Text] [Related]
11. Modelling Study with an Interactive Model Assessing the Cost-effectiveness of
Scholte M; Barentsz JO; Sedelaar JPM; Gotthardt M; Grutters JPC; Rovers MM
Eur Urol Focus; 2020 Sep; 6(5):967-974. PubMed ID: 30826284
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.
Meads C; Auguste P; Davenport C; Małysiak S; Sundar S; Kowalska M; Zapalska A; Guest P; Thangaratinam S; Martin-Hirsch P; Borowiack E; Barton P; Roberts T; Khan K
Health Technol Assess; 2013 Mar; 17(12):1-323. PubMed ID: 23537558
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective.
de Rooij M; Crienen S; Witjes JA; Barentsz JO; Rovers MM; Grutters JP
Eur Urol; 2014 Sep; 66(3):430-6. PubMed ID: 24377803
[TBL] [Abstract][Full Text] [Related]
14. Follow-Up 18F-FDG PET/CT versus Contrast-Enhanced CT after Ablation of Liver Metastases of Colorectal Carcinoma-A Cost-Effectiveness Analysis.
Schnitzer ML; Froelich MF; Gassert FG; Huber T; Gresser E; Schwarze V; Nörenberg D; Todica A; Rübenthaler J
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32867107
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
Campbell F; Thokala P; Uttley LC; Sutton A; Sutton AJ; Al-Mohammad A; Thomas SM
Health Technol Assess; 2014 Sep; 18(59):1-120. PubMed ID: 25265259
[TBL] [Abstract][Full Text] [Related]
16. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of CT, CTA, MRI, and Specialized MRI for Evaluation of Patients Presenting to the Emergency Department With Dizziness.
Tu LH; Melnick E; Venkatesh AK; Sheth KN; Navaratnam D; Yaesoubi R; Forman HP; Mahajan A
AJR Am J Roentgenol; 2024 Feb; 222(2):e2330060. PubMed ID: 37937837
[No Abstract] [Full Text] [Related]
18. PET-Based Staging Is Cost-Effective in Early-Stage Follicular Lymphoma.
Lo AC; James LP; Prica A; Raymakers A; Peacock S; Qu M; Louie AV; Savage KJ; Sehn LH; Hodgson D; Yang JC; Eich HTT; Wirth A; Hunink MGM
J Nucl Med; 2022 Apr; 63(4):543-548. PubMed ID: 34413148
[TBL] [Abstract][Full Text] [Related]
19. Different Imaging Strategies in Patients With Possible Basilar Artery Occlusion: Cost-Effectiveness Analysis.
Beyer SE; Hunink MG; Schöberl F; von Baumgarten L; Petersen SE; Dichgans M; Janssen H; Ertl-Wagner B; Reiser MF; Sommer WH
Stroke; 2015 Jul; 46(7):1840-9. PubMed ID: 26022634
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of contrast-enhanced ultrasound for the detection of endovascular aneurysm repair-related endoleaks requiring treatment.
Froelich MF; Kunz WG; Kim SH; Sommer WH; Clevert DA; Rübenthaler J
J Vasc Surg; 2021 Jan; 73(1):232-239.e2. PubMed ID: 32442612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]